NCT04433104View on ClinicalTrials.gov

Umbilical Cord Mesenchymal Stem Cells Transplantation in the Treatment of Chronic Obstructive Pulmonary Disease

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 9, 2020

Primary Completion Date

July 30, 2021

Study Completion Date

December 25, 2022

Conditions
COPD
Interventions
BIOLOGICAL

Umbilical Cord Mesenchymal Stem Cells transplantation

Patients assigned to UC-MSC administration groups will receive two administrations at a dose of 1 million cells/kg patient body weight via the IV route with a 3-month intervening interval

DRUG

drug therapy according to Vietnamese MOHS procedure

Salbutamol, Terbutaline

Trial Locations (1)

100000

Vinmec International Hospital Times City, Hanoi

All Listed Sponsors
lead

Vinmec Research Institute of Stem Cell and Gene Technology

OTHER

NCT04433104 - Umbilical Cord Mesenchymal Stem Cells Transplantation in the Treatment of Chronic Obstructive Pulmonary Disease | Biotech Hunter | Biotech Hunter